Ilex Medical (XTAE:ILX) EV-to-EBIT : 7.17 (As of Jun. 24, 2024)

Ilex Medical EV-to-EBIT Chart

Ilex Medical Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial					10.73	8.20	6.26	6.57	6.90

Ilex Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															8.40	5.83	7.41	6.90	7.66

Competitive Comparison of Ilex Medical's EV-to-EBIT

For the Medical Devices subindustry, Ilex Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ilex Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ilex Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ilex Medical's EV-to-EBIT falls into.

Ilex Medical EV-to-EBIT Calculation

Ilex Medical's EV-to-EBIT for today is calculated as:

Ilex Medical's current Enterprise Value is ₪510.4 Mil.
Ilex Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪71.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ilex Medical  (XTAE:ILX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Ilex Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Ilex Medical's Enterprise Value for the quarter that ended in Mar. 2024 was ₪545.0 Mil.
Ilex Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪71.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ilex Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Ilex Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Ilex Medical (XTAE:ILX) Business Description